Nature Cell acquires approval of Phase 1/2 clinical trials for dementia treatment from US FDA

Clinical trials to treat American Alzheimer’s disease patients with stem cells manufactured in Korea were approved by the U.S. FDA.

Nature Cell(CEO Jung-Chan La) announced it acquired approval of the Astrostem’s Phase 1 & 2 clinical trial plans applied on the 21^st of October for Alzheimer’s disease and dementia from the U.S. FDA on the 23^rd.  

Astrostem is an adult stem cell therapy injected ...